Tetrazole regioisomers in the development of nitro group-containing antitubercular agents (Q58260404)

Marcela Vejsová

8

0 references

Jaroslav Roh

Jaroslav Roh

2

0 references

Věra Klimešová

Věra Klimešová

10

0 references

Alexandr Hrabálek

Alexandr Hrabálek

11

0 references

author name string

Ondřej Soukup

3

0 references

Ivona Pávková

4

0 references

Markéta Pasdiorová

5

0 references

Vojtěch Tambor

6

0 references

Jiřina Stolaříková

7

0 references

Kateřina Vávrová

Advances in the development of new tuberculosis drugs and treatment regimens

9

0 references

publication date

2015

0 references

published in

MedChemComm

0 references

volume

6

0 references

issue

1

0 references

page(s)

174-181

0 references

cites work

1 reference

Antituberculosis drug research: a critical overview.

21 January 2018

1 reference

Recent advances in the research of heterocyclic compounds as antitubercular agents

21 January 2018

1 reference

New drugs for the treatment of tuberculosis: needs, challenges, promise, and prospects for the future

21 January 2018

1 reference

Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models

21 January 2018

1 reference

OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice

21 January 2018

1 reference

Delamanid for Multidrug-Resistant Pulmonary Tuberculosis

21 January 2018

1 reference

High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors

21 January 2018

1 reference

Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis

21 January 2018

1 reference

Benzothiazinones are suicide inhibitors of mycobacterial decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1.

21 January 2018

1 reference

Towards a new combination therapy for tuberculosis with next generation benzothiazinones

21 January 2018

1 reference

Synthesis and antimycobacterial activity of 2-substituted halogenobenzimidazoles

21 January 2018

1 reference

Synthesis and preliminary evaluation of benzimidazole derivatives as antimicrobial agents.

21 January 2018

1 reference

Heterocyclic benzazole derivatives with antimycobacterial in vitro activity.

21 January 2018

1 reference

Structure-Activity Relationships of 2-Benzylsulfanylbenzothiazoles: Synthesis and Selective Antimycobacterial Properties

21 January 2018

1 reference

1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria

21 January 2018

1 reference

Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation

21 January 2018

1 reference

Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase

21 January 2018

1 reference

Heme oxygenase inhibition by 2-oxy-substituted 1-azolyl-4-phenylbutanes: effect of variation of the azole moiety. X-ray crystal structure of human heme oxygenase-1 in complex with 4-phenyl-1-(1H-1,2,4-triazol-1-yl)-2-butanone

21 January 2018

1 reference

Novel Pseudomonas aeruginosa quorum-sensing inhibitors identified in an ultra-high-throughput screen.

21 January 2018

1 reference

The mechanism of action of PA-824: Novel insights from transcriptional profiling

21 January 2018

1 reference